Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director · Chairman and CEO | March 15, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,945 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 52,945 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
ICU MEDICAL INC/DE
Report date March 15, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,106 |
Reported balance
After 2026-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-15 · Exercise / conversion · Acquired 17,100 · Balance 134,106 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Direct | 124,654 |
Reported balance
After 2026-03-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-15 · Tax withholding · Disposed 9,452 · Balance 124,654 F1: These Securities are Performance-based Restricted Stock Units (PRSU). |
| Common StockSEC Table I · non-derivative | Direct | 129,526 |
Reported balance
After 2026-03-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-03-15 · Exercise / conversion · Acquired 4,872 · Balance 129,526 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table I · non-derivative | Direct | 126,833 |
Reported balance
After 2026-03-15 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-03-15 · Tax withholding · Disposed 2,693 · Balance 126,833 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-15 · Exercise / conversion · Disposed 4,872 · Balance 0 F3: These securities are Restricted Stock Units. F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units. |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-15 · Exercise / conversion · Disposed 17,100 · Balance 0 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F5: There is neither a purchase price nor an exercise price for the PRSUs. F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 152,339 |
Reported balance
Holding disclosure · report date 2026-03-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 152,339 |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
F3: These securities are Restricted Stock Units.
F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F5: There is neither a purchase price nor an exercise price for the PRSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 4,440 | $163.59 | $726,326.28 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,593 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.99 to $163.96, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 4,440 | $88.76 | $394,094.40 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,755 | $162.69 | $610,915.97 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,593 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.98 to $162.94, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,755 | $88.76 | $333,293.80 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| August 16, 2024 Filed Aug 16, 2024 21:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $88.76 | $0.00 |
DisclosureSEC source: 0001410442-24-000004 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,373 Underlying: Common Stock · 12,000 shares Expires 2025-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| August 16, 2024 Filed Aug 16, 2024 21:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 12,000 | $156.04 | $1,872,480.00 |
DisclosureSEC source: 0001410442-24-000004 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,593 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| August 16, 2024 Filed Aug 16, 2024 21:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 12,000 | $88.76 | $1,065,120.00 |
DisclosureSEC source: 0001410442-24-000004 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:32 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 10,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-24-000050 · wk-form4_1716496341.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,165 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 4,871 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000003 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,744 Underlying: Common Stock · 4,871 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 2,671 | $98.08 | $261,971.68 |
DisclosureSEC source: 0001410442-24-000003 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,593 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 4,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000003 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 8,331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 13 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,331 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,525 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,525 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 4,569 | $104.52 | $477,551.88 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,393 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 8,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,384 | $104.52 | $144,655.68 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,631 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 19,306 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 12 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,306 shares Expires 2024-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F7 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,218 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,218 Underlying: Common Stock · 3,218 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 10,588 | $105.39 | $1,115,869.32 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,490 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 19,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,764 | $105.39 | $185,907.96 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,772 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 66,000 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-24-000001 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 0 Underlying: Common Stock · 66,000 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.expiration_date: These non-qualified stock options were granted on 2/24/2014 with a ten year life with an expiration date of 2/24/2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 146,366 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-24-000001 · edgardoc.xml · derivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 146,366 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.expiration_date: These non-qualified stock options were granted on 2/24/2014 with a ten year life with an expiration date of 2/24/2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 37,302 | $104.02 | $3,880,154.04 |
DisclosureSEC source: 0001410442-24-000001 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 88,698 F1 · kind: Mr. Jain (the Registrant) was personally responsible for cash tax obligations of approximately $5 million in total related to all net exercises reported on this Form 4, shares were not traded in lieu of taxes paid. F3 · shares: Represents a "net exercise" of outstanding stock options. The trusts received 28,698 shares of common stock on net exercise of option to purchase 66,000 shares of common stock. The company withheld 37,302 shares of common stock underlying the option for payment of the exercise price, using the closing stock price on February 12, 2024 of $104.02. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 66,000 | $58.79 | $3,880,140.00 |
DisclosureSEC source: 0001410442-24-000001 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 126,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 82,725 | $104.02 | $8,605,054.50 |
DisclosureSEC source: 0001410442-24-000001 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,318 F1 · kind: Mr. Jain (the Registrant) was personally responsible for cash tax obligations of approximately $5 million in total related to all net exercises reported on this Form 4, shares were not traded in lieu of taxes paid. F2 · shares: Represents a "net exercise" of outstanding stock options. The reporting person received 63,641 shares of common stock on net exercise of option to purchase 146,366 shares of common stock. The company withheld 82,725 shares of common stock underlying the option for payment of the exercise price, using the closing stock price on February 12, 2024 of $104.02. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 146,366 | $58.79 | $8,604,857.14 |
DisclosureSEC source: 0001410442-24-000001 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 21:36 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000005 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,366 Underlying: Common Stock · 30,000 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 21:36 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 30,000 | $180.02 | $5,400,720.00 |
DisclosureSEC source: 0001410442-23-000005 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 to $180.215, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 21:36 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 30,000 | $58.79 | $1,763,700.00 |
DisclosureSEC source: 0001410442-23-000005 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 100 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 31 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,366 Underlying: Common Stock · 100 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,418 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 30 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,466 Underlying: Common Stock · 2,418 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,104 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 29 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,884 Underlying: Common Stock · 2,104 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,601 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 28 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,988 Underlying: Common Stock · 1,601 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,699 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 27 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,589 Underlying: Common Stock · 1,699 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 785 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 26 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 184,288 Underlying: Common Stock · 785 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,163 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 25 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,073 Underlying: Common Stock · 8,163 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,781 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 24 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 193,236 Underlying: Common Stock · 2,781 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,637 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 23 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,017 Underlying: Common Stock · 3,637 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,712 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · derivative · entry 22 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 199,654 Underlying: Common Stock · 6,712 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,104 | $193.30 | $406,694.78 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 20 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.52 to $193.515, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 100 | $194.73 | $19,473.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 19 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,781 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F10 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 100 | $58.79 | $5,879.00 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 18 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,418 | $194.02 | $469,144.95 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 17 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,781 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.58 to $194.21, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,418 | $58.79 | $142,154.22 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 16 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,104 | $58.79 | $123,694.16 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 15 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,601 | $192.06 | $307,490.14 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 14 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.44 to $192.385, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,601 | $58.79 | $94,122.79 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 13 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.